IMDX IMDX US — Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by IMDX in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: IMDX’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about IMDX's us — revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is IMDX's US — revenue?
- IMDX (IMDX) reported US — revenue of $32K in Q1 2026.
- How has IMDX's US — revenue changed year-over-year?
- IMDX's US — revenue decreased by 98.5% year-over-year, from $2.14M to $32K.
- What is the long-term trend for IMDX's US — revenue?
- Over 2 years (2023 to 2025), IMDX's US — revenue has grown at a 109.0% compound annual growth rate (CAGR), from $923K to $4.03M.
- What does US — revenue mean?
- This metric represents the total gross revenue generated from sales of molecular diagnostic products and services within the United States market, net of any collected sales taxes. It serves as a primary indicator of market adoption for the company's diagnostic technology and the commercial success of its product portfolio in the region. Tracking this figure allows investors to assess the growth trajectory and revenue scalability of the company's core diagnostic offerings.